Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort

7 Sept 2023

Abstract excerpt

OBJECTIVE: Identify patient preference towards thrombopoietin-receptor agonists (TPO-RAs) and determine the clinical and social impact of immune thrombocytopenia (ITP) in Italy. METHODS: The Thrombopoietin-Receptor Agonist Patient experience (TRAPeze) survey collected responses from Italian residents from 17th January to 28th February 2022. TRAPeze utilized a discrete choice experiment (DCE) to elicit patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Heparin-Induced Thrombocytopenia and Thrombosis
Share to Platelet Disorders and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37680028
DOI: 10.1080/16078454.2023.2253069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohortPMID 37680028Read ↗

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysisSemantic proximity Read ↗

Health-related quality of life and complications of corticosteroid treatment in patients with immune thrombocytopenia in two teaching hospitals in Ethiopia: A cross-sectional studySemantic proximity Read ↗

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for PharmacistsSemantic proximity Read ↗

Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problemSemantic proximity Read ↗

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopeniaSemantic proximity Read ↗

Gastrointestinal adverse events associated with Riociguat: A pharmacovigilance study based on FDA adverse event reporting systemSemantic proximity Read ↗

Self-Reported Side Effects Among Reddit Users Taking Unapproved RetatrutideSemantic proximity Read ↗

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin TherapySemantic proximity Read ↗

Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpuraSemantic proximity Read ↗

Patient demographics, medical factors, treatment modalities and satisfaction at five traditional Chinese medicine practices: A cross-sectional studySemantic proximity Read ↗

The importance of real-world data in evaluating the safety of biosimilars: a descriptive study of clinical practice in an oncohematological population.Semantic proximity Read ↗

Real-life use of ropeg-interferon α2b in Polycythemia Vera: patient selection and clinical outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.